BioSupply Trends Quarterly logo
Search
Close this search box.

FDA Retires Monovalent COVID-19 Vaccines

FDA Retires Monovalent COVID-19 Vaccines

The U.S. Food and Drug Administration has amended the emergency use authorizations of the. Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals.

First Once-Daily Oral Plaque Psoriasis Drug Approved by FDA

Plaque Psoriasis

The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib), a once-daily oral pill by Bristol Myers Squibb, for adults who have plaque psoriasis (a chronic, systemic, immune-mediated disease) severe enough to make them candidates for systemic therapy and phototherapy.

FDA Approves Humira Biosimilar to Treat Autoimmune Disorders

psoriatic arthritis autoimmune disorder

The U.S. Food and Drug Administration has approved Samsung Bioepis; Halima (adalimumab-bwwd) for the treatment of several autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn’s disease.

FDA Approves Argenx’s Vyvgart to Treat MG

Illustration of a neuron

The U.S. Food and Drug Administration (FDA) has approved Vyvgart (efgartigi-mod) to treat generalized myasthenia gravis (gMG) in adults who test positive for the anti-acetylcholine receptor (AChR) antibody.

FDA Implements New Warnings for Cigarette Packages and Advertisements

Cigarette package warning

The U.S. Food and Drug Administration (FDA) issued a final rule to require new health warnings on cigarette packages and in cigarette advertisements, which feature textual statements with photo-realistic color images depicting some of the lesser-known, but serious health risks of cigarette smoking, including impact to fetal growth, cardiac disease, diabetes and more.